Mallinckrodt Ireland Drug Patent Portfolio
Mallinckrodt Ireland owns 3 orange book drugs protected by 2 US patents Given below is the list of Mallinckrodt Ireland's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11752199 | Methods of modulating pericytes | 25 Feb, 2041 | Active |
| US10335452 | Method of treating patients with hepatorenal syndrome type 1 | 05 Apr, 2037 | Active |
Latest Legal Activities on Mallinckrodt Ireland's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Mallinckrodt Ireland.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Sep, 2023 | US11752199 |
|
Email Notification
Critical
| 12 Sep, 2023 | US11752199 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Sep, 2023 | US11752199 |
| Recordation of Patent eGrant | 12 Sep, 2023 | US11752199 |
| Sequence Moved to Public Database | 12 Sep, 2023 | US11752199 |
| Mail Patent eGrant Notification | 12 Sep, 2023 | US11752199 |
| Patent eGrant Notification | 12 Sep, 2023 | US11752199 |
|
Email Notification
Critical
| 24 Aug, 2023 | US11752199 |
|
Issue Notification Mailed
Critical
| 23 Aug, 2023 | US11752199 |
|
Application Is Considered Ready for Issue
Critical
| 02 Aug, 2023 | US11752199 |
| Dispatch to FDC | 02 Aug, 2023 | US11752199 |
|
Issue Fee Payment Received
Critical
| 01 Aug, 2023 | US11752199 |
|
Issue Fee Payment Verified
Critical
| 01 Aug, 2023 | US11752199 |
| Sequence Forwarded to Pubs on Tape | 03 May, 2023 | US11752199 |
|
Mail Notice of Allowance
Critical
| 02 May, 2023 | US11752199 |
Mallinckrodt Ireland's Family Patents
Mallinckrodt Ireland Drug List
Given below is the complete list of Mallinckrodt Ireland's drugs and the patents protecting them.
1. Acthar Gel
Acthar Gel is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11752199 | Methods of modulating pericytes |
25 Feb, 2041
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acthar Gel's drug page
2. Acthar Gel (autoinjector)
Acthar Gel (autoinjector) is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11752199 | Methods of modulating pericytes |
25 Feb, 2041
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Acthar Gel (autoinjector)'s drug page
3. Terlivaz
Terlivaz is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10335452 | Method of treating patients with hepatorenal syndrome type 1 |
05 Apr, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Terlivaz's drug page